nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Alkylating Activity—Dacarbazine—pancreatic cancer	0.752	1	CiPCiCtD
Thiotepa—CYP2B6—Tamoxifen—pancreatic cancer	0.0406	0.289	CbGbCtD
Thiotepa—CYP2B6—Irinotecan—pancreatic cancer	0.0311	0.222	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—pancreatic cancer	0.017	0.121	CbGbCtD
Thiotepa—CYP3A4—Tamoxifen—pancreatic cancer	0.0125	0.0887	CbGbCtD
Thiotepa—CYP3A4—Erlotinib—pancreatic cancer	0.0106	0.0754	CbGbCtD
Thiotepa—CYP3A4—Irinotecan—pancreatic cancer	0.00957	0.0681	CbGbCtD
Thiotepa—CYP3A4—Docetaxel—pancreatic cancer	0.00701	0.0499	CbGbCtD
Thiotepa—CYP3A4—Sunitinib—pancreatic cancer	0.00698	0.0497	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—pancreatic cancer	0.00523	0.0372	CbGbCtD
Thiotepa—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	6.09e-05	0.000567	CcSEcCtD
Thiotepa—Fatigue—Gemcitabine—pancreatic cancer	6.09e-05	0.000567	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	6.06e-05	0.000564	CcSEcCtD
Thiotepa—Cardiac arrest—Doxorubicin—pancreatic cancer	6.05e-05	0.000563	CcSEcCtD
Thiotepa—Constipation—Gemcitabine—pancreatic cancer	6.04e-05	0.000562	CcSEcCtD
Thiotepa—Pain—Gemcitabine—pancreatic cancer	6.04e-05	0.000562	CcSEcCtD
Thiotepa—Nausea—Erlotinib—pancreatic cancer	6.04e-05	0.000562	CcSEcCtD
Thiotepa—Decreased appetite—Fluorouracil—pancreatic cancer	6.03e-05	0.000562	CcSEcCtD
Thiotepa—Diarrhoea—Sunitinib—pancreatic cancer	6.02e-05	0.00056	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	5.99e-05	0.000558	CcSEcCtD
Thiotepa—Ataxia—Doxorubicin—pancreatic cancer	5.98e-05	0.000557	CcSEcCtD
Thiotepa—Feeling abnormal—Irinotecan—pancreatic cancer	5.97e-05	0.000556	CcSEcCtD
Thiotepa—Blood creatinine increased—Doxorubicin—pancreatic cancer	5.96e-05	0.000555	CcSEcCtD
Thiotepa—Back pain—Docetaxel—pancreatic cancer	5.94e-05	0.000553	CcSEcCtD
Thiotepa—Pain—Fluorouracil—pancreatic cancer	5.94e-05	0.000552	CcSEcCtD
Thiotepa—Gastrointestinal pain—Irinotecan—pancreatic cancer	5.93e-05	0.000552	CcSEcCtD
Thiotepa—Dehydration—Doxorubicin—pancreatic cancer	5.92e-05	0.000551	CcSEcCtD
Thiotepa—Dizziness—Sunitinib—pancreatic cancer	5.82e-05	0.000542	CcSEcCtD
Thiotepa—Feeling abnormal—Gemcitabine—pancreatic cancer	5.82e-05	0.000541	CcSEcCtD
Thiotepa—Abdominal pain—Irinotecan—pancreatic cancer	5.73e-05	0.000533	CcSEcCtD
Thiotepa—Body temperature increased—Irinotecan—pancreatic cancer	5.73e-05	0.000533	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	5.73e-05	0.000533	CcSEcCtD
Thiotepa—Feeling abnormal—Fluorouracil—pancreatic cancer	5.72e-05	0.000532	CcSEcCtD
Thiotepa—Anaemia—Docetaxel—pancreatic cancer	5.67e-05	0.000528	CcSEcCtD
Thiotepa—Pancytopenia—Epirubicin—pancreatic cancer	5.64e-05	0.000525	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	5.61e-05	0.000522	CcSEcCtD
Thiotepa—Vomiting—Sunitinib—pancreatic cancer	5.59e-05	0.000521	CcSEcCtD
Thiotepa—Body temperature increased—Gemcitabine—pancreatic cancer	5.58e-05	0.000519	CcSEcCtD
Thiotepa—Dysuria—Epirubicin—pancreatic cancer	5.56e-05	0.000517	CcSEcCtD
Thiotepa—Rash—Sunitinib—pancreatic cancer	5.55e-05	0.000516	CcSEcCtD
Thiotepa—Dermatitis—Sunitinib—pancreatic cancer	5.54e-05	0.000516	CcSEcCtD
Thiotepa—Urticaria—Fluorouracil—pancreatic cancer	5.51e-05	0.000513	CcSEcCtD
Thiotepa—Headache—Sunitinib—pancreatic cancer	5.51e-05	0.000513	CcSEcCtD
Thiotepa—Leukopenia—Docetaxel—pancreatic cancer	5.49e-05	0.000511	CcSEcCtD
Thiotepa—Body temperature increased—Fluorouracil—pancreatic cancer	5.49e-05	0.000511	CcSEcCtD
Thiotepa—Weight increased—Epirubicin—pancreatic cancer	5.41e-05	0.000503	CcSEcCtD
Thiotepa—Hyperglycaemia—Epirubicin—pancreatic cancer	5.36e-05	0.000499	CcSEcCtD
Thiotepa—Cough—Docetaxel—pancreatic cancer	5.36e-05	0.000499	CcSEcCtD
Thiotepa—Hypersensitivity—Irinotecan—pancreatic cancer	5.34e-05	0.000497	CcSEcCtD
Thiotepa—Pneumonia—Epirubicin—pancreatic cancer	5.33e-05	0.000496	CcSEcCtD
Thiotepa—Convulsion—Docetaxel—pancreatic cancer	5.32e-05	0.000495	CcSEcCtD
Thiotepa—Hypertension—Docetaxel—pancreatic cancer	5.3e-05	0.000493	CcSEcCtD
Thiotepa—Infestation NOS—Epirubicin—pancreatic cancer	5.3e-05	0.000493	CcSEcCtD
Thiotepa—Infestation—Epirubicin—pancreatic cancer	5.3e-05	0.000493	CcSEcCtD
Thiotepa—Myalgia—Docetaxel—pancreatic cancer	5.23e-05	0.000486	CcSEcCtD
Thiotepa—Arthralgia—Docetaxel—pancreatic cancer	5.23e-05	0.000486	CcSEcCtD
Thiotepa—Nausea—Sunitinib—pancreatic cancer	5.23e-05	0.000486	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—pancreatic cancer	5.22e-05	0.000486	CcSEcCtD
Thiotepa—Renal failure—Epirubicin—pancreatic cancer	5.21e-05	0.000485	CcSEcCtD
Thiotepa—Asthenia—Irinotecan—pancreatic cancer	5.2e-05	0.000484	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	5.19e-05	0.000483	CcSEcCtD
Thiotepa—Stomatitis—Epirubicin—pancreatic cancer	5.16e-05	0.000481	CcSEcCtD
Thiotepa—Jaundice—Epirubicin—pancreatic cancer	5.16e-05	0.000481	CcSEcCtD
Thiotepa—Conjunctivitis—Epirubicin—pancreatic cancer	5.15e-05	0.000479	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—pancreatic cancer	5.14e-05	0.000479	CcSEcCtD
Thiotepa—Hypersensitivity—Fluorouracil—pancreatic cancer	5.11e-05	0.000476	CcSEcCtD
Thiotepa—Asthenia—Gemcitabine—pancreatic cancer	5.06e-05	0.000471	CcSEcCtD
Thiotepa—Haematuria—Epirubicin—pancreatic cancer	5.05e-05	0.00047	CcSEcCtD
Thiotepa—Confusional state—Docetaxel—pancreatic cancer	5.05e-05	0.00047	CcSEcCtD
Thiotepa—Hepatobiliary disease—Epirubicin—pancreatic cancer	5.01e-05	0.000466	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—pancreatic cancer	5e-05	0.000466	CcSEcCtD
Thiotepa—Epistaxis—Epirubicin—pancreatic cancer	5e-05	0.000465	CcSEcCtD
Thiotepa—Pruritus—Gemcitabine—pancreatic cancer	4.99e-05	0.000465	CcSEcCtD
Thiotepa—Infection—Docetaxel—pancreatic cancer	4.98e-05	0.000463	CcSEcCtD
Thiotepa—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.96e-05	0.000462	CcSEcCtD
Thiotepa—Diarrhoea—Irinotecan—pancreatic cancer	4.96e-05	0.000462	CcSEcCtD
Thiotepa—Agranulocytosis—Epirubicin—pancreatic cancer	4.94e-05	0.00046	CcSEcCtD
Thiotepa—Pneumonia—Doxorubicin—pancreatic cancer	4.93e-05	0.000459	CcSEcCtD
Thiotepa—Nervous system disorder—Docetaxel—pancreatic cancer	4.91e-05	0.000457	CcSEcCtD
Thiotepa—Pruritus—Fluorouracil—pancreatic cancer	4.91e-05	0.000457	CcSEcCtD
Thiotepa—Thrombocytopenia—Docetaxel—pancreatic cancer	4.9e-05	0.000457	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—pancreatic cancer	4.9e-05	0.000456	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—pancreatic cancer	4.9e-05	0.000456	CcSEcCtD
Thiotepa—Tachycardia—Docetaxel—pancreatic cancer	4.89e-05	0.000455	CcSEcCtD
Thiotepa—Skin disorder—Docetaxel—pancreatic cancer	4.87e-05	0.000453	CcSEcCtD
Thiotepa—Diarrhoea—Gemcitabine—pancreatic cancer	4.83e-05	0.00045	CcSEcCtD
Thiotepa—Renal failure—Doxorubicin—pancreatic cancer	4.82e-05	0.000449	CcSEcCtD
Thiotepa—Dizziness—Irinotecan—pancreatic cancer	4.79e-05	0.000446	CcSEcCtD
Thiotepa—Haemoglobin—Epirubicin—pancreatic cancer	4.78e-05	0.000445	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—pancreatic cancer	4.78e-05	0.000445	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—pancreatic cancer	4.78e-05	0.000445	CcSEcCtD
Thiotepa—Anorexia—Docetaxel—pancreatic cancer	4.78e-05	0.000444	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—pancreatic cancer	4.76e-05	0.000444	CcSEcCtD
Thiotepa—Haemorrhage—Epirubicin—pancreatic cancer	4.76e-05	0.000443	CcSEcCtD
Thiotepa—Diarrhoea—Fluorouracil—pancreatic cancer	4.75e-05	0.000442	CcSEcCtD
Thiotepa—Urinary tract disorder—Epirubicin—pancreatic cancer	4.7e-05	0.000437	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—pancreatic cancer	4.67e-05	0.000435	CcSEcCtD
Thiotepa—Connective tissue disorder—Epirubicin—pancreatic cancer	4.67e-05	0.000435	CcSEcCtD
Thiotepa—Urethral disorder—Epirubicin—pancreatic cancer	4.66e-05	0.000434	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—pancreatic cancer	4.64e-05	0.000432	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—pancreatic cancer	4.62e-05	0.00043	CcSEcCtD
Thiotepa—Vomiting—Irinotecan—pancreatic cancer	4.61e-05	0.000429	CcSEcCtD
Thiotepa—Dizziness—Fluorouracil—pancreatic cancer	4.59e-05	0.000427	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—pancreatic cancer	4.57e-05	0.000426	CcSEcCtD
Thiotepa—Rash—Irinotecan—pancreatic cancer	4.57e-05	0.000425	CcSEcCtD
Thiotepa—Dermatitis—Irinotecan—pancreatic cancer	4.56e-05	0.000425	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.56e-05	0.000425	CcSEcCtD
Thiotepa—Headache—Irinotecan—pancreatic cancer	4.54e-05	0.000423	CcSEcCtD
Thiotepa—Paraesthesia—Docetaxel—pancreatic cancer	4.5e-05	0.000419	CcSEcCtD
Thiotepa—Vomiting—Gemcitabine—pancreatic cancer	4.49e-05	0.000418	CcSEcCtD
Thiotepa—Somnolence—Docetaxel—pancreatic cancer	4.45e-05	0.000415	CcSEcCtD
Thiotepa—Rash—Gemcitabine—pancreatic cancer	4.45e-05	0.000414	CcSEcCtD
Thiotepa—Dermatitis—Gemcitabine—pancreatic cancer	4.45e-05	0.000414	CcSEcCtD
Thiotepa—Eye disorder—Epirubicin—pancreatic cancer	4.44e-05	0.000414	CcSEcCtD
Thiotepa—Tinnitus—Epirubicin—pancreatic cancer	4.43e-05	0.000413	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—pancreatic cancer	4.42e-05	0.000412	CcSEcCtD
Thiotepa—Headache—Gemcitabine—pancreatic cancer	4.42e-05	0.000412	CcSEcCtD
Thiotepa—Cardiac disorder—Epirubicin—pancreatic cancer	4.41e-05	0.000411	CcSEcCtD
Thiotepa—Vomiting—Fluorouracil—pancreatic cancer	4.41e-05	0.000411	CcSEcCtD
Thiotepa—Dyspepsia—Docetaxel—pancreatic cancer	4.41e-05	0.00041	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—pancreatic cancer	4.4e-05	0.00041	CcSEcCtD
Thiotepa—Rash—Fluorouracil—pancreatic cancer	4.38e-05	0.000407	CcSEcCtD
Thiotepa—Dermatitis—Fluorouracil—pancreatic cancer	4.37e-05	0.000407	CcSEcCtD
Thiotepa—Decreased appetite—Docetaxel—pancreatic cancer	4.35e-05	0.000405	CcSEcCtD
Thiotepa—Headache—Fluorouracil—pancreatic cancer	4.35e-05	0.000405	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—pancreatic cancer	4.35e-05	0.000405	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.32e-05	0.000403	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—pancreatic cancer	4.32e-05	0.000403	CcSEcCtD
Thiotepa—Fatigue—Docetaxel—pancreatic cancer	4.32e-05	0.000402	CcSEcCtD
Thiotepa—Angiopathy—Epirubicin—pancreatic cancer	4.31e-05	0.000402	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—pancreatic cancer	4.31e-05	0.000402	CcSEcCtD
Thiotepa—Nausea—Irinotecan—pancreatic cancer	4.3e-05	0.000401	CcSEcCtD
Thiotepa—Immune system disorder—Epirubicin—pancreatic cancer	4.3e-05	0.0004	CcSEcCtD
Thiotepa—Mediastinal disorder—Epirubicin—pancreatic cancer	4.29e-05	0.000399	CcSEcCtD
Thiotepa—Pain—Docetaxel—pancreatic cancer	4.28e-05	0.000399	CcSEcCtD
Thiotepa—Constipation—Docetaxel—pancreatic cancer	4.28e-05	0.000399	CcSEcCtD
Thiotepa—Chills—Epirubicin—pancreatic cancer	4.27e-05	0.000397	CcSEcCtD
Thiotepa—Arrhythmia—Epirubicin—pancreatic cancer	4.25e-05	0.000395	CcSEcCtD
Thiotepa—Alopecia—Epirubicin—pancreatic cancer	4.2e-05	0.000391	CcSEcCtD
Thiotepa—Nausea—Gemcitabine—pancreatic cancer	4.19e-05	0.00039	CcSEcCtD
Thiotepa—Mental disorder—Epirubicin—pancreatic cancer	4.17e-05	0.000388	CcSEcCtD
Thiotepa—Erythema—Epirubicin—pancreatic cancer	4.14e-05	0.000385	CcSEcCtD
Thiotepa—Malnutrition—Epirubicin—pancreatic cancer	4.14e-05	0.000385	CcSEcCtD
Thiotepa—Feeling abnormal—Docetaxel—pancreatic cancer	4.13e-05	0.000384	CcSEcCtD
Thiotepa—Nausea—Fluorouracil—pancreatic cancer	4.12e-05	0.000384	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—pancreatic cancer	4.11e-05	0.000383	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—pancreatic cancer	4.1e-05	0.000382	CcSEcCtD
Thiotepa—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.1e-05	0.000381	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—pancreatic cancer	4.08e-05	0.00038	CcSEcCtD
Thiotepa—Tension—Epirubicin—pancreatic cancer	4.06e-05	0.000378	CcSEcCtD
Thiotepa—Nervousness—Epirubicin—pancreatic cancer	4.02e-05	0.000374	CcSEcCtD
Thiotepa—Back pain—Epirubicin—pancreatic cancer	4e-05	0.000373	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—pancreatic cancer	3.99e-05	0.000372	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—pancreatic cancer	3.97e-05	0.00037	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—pancreatic cancer	3.97e-05	0.000369	CcSEcCtD
Thiotepa—Abdominal pain—Docetaxel—pancreatic cancer	3.96e-05	0.000369	CcSEcCtD
Thiotepa—Body temperature increased—Docetaxel—pancreatic cancer	3.96e-05	0.000369	CcSEcCtD
Thiotepa—Chills—Doxorubicin—pancreatic cancer	3.95e-05	0.000368	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—pancreatic cancer	3.93e-05	0.000366	CcSEcCtD
Thiotepa—Vision blurred—Epirubicin—pancreatic cancer	3.9e-05	0.000363	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—pancreatic cancer	3.89e-05	0.000362	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—pancreatic cancer	3.86e-05	0.000359	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—pancreatic cancer	3.83e-05	0.000357	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—pancreatic cancer	3.83e-05	0.000357	CcSEcCtD
Thiotepa—Anaemia—Epirubicin—pancreatic cancer	3.83e-05	0.000356	CcSEcCtD
Thiotepa—Agitation—Epirubicin—pancreatic cancer	3.8e-05	0.000354	CcSEcCtD
Thiotepa—Tension—Doxorubicin—pancreatic cancer	3.76e-05	0.00035	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—pancreatic cancer	3.72e-05	0.000346	CcSEcCtD
Thiotepa—Leukopenia—Epirubicin—pancreatic cancer	3.71e-05	0.000345	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—pancreatic cancer	3.71e-05	0.000345	CcSEcCtD
Thiotepa—Hypersensitivity—Docetaxel—pancreatic cancer	3.69e-05	0.000344	CcSEcCtD
Thiotepa—Cough—Epirubicin—pancreatic cancer	3.61e-05	0.000336	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—pancreatic cancer	3.61e-05	0.000336	CcSEcCtD
Thiotepa—Asthenia—Docetaxel—pancreatic cancer	3.59e-05	0.000335	CcSEcCtD
Thiotepa—Convulsion—Epirubicin—pancreatic cancer	3.59e-05	0.000334	CcSEcCtD
Thiotepa—Hypertension—Epirubicin—pancreatic cancer	3.57e-05	0.000333	CcSEcCtD
Thiotepa—Pruritus—Docetaxel—pancreatic cancer	3.54e-05	0.00033	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—pancreatic cancer	3.54e-05	0.00033	CcSEcCtD
Thiotepa—Myalgia—Epirubicin—pancreatic cancer	3.52e-05	0.000328	CcSEcCtD
Thiotepa—Arthralgia—Epirubicin—pancreatic cancer	3.52e-05	0.000328	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—pancreatic cancer	3.52e-05	0.000328	CcSEcCtD
Thiotepa—Anxiety—Epirubicin—pancreatic cancer	3.51e-05	0.000327	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.5e-05	0.000326	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—pancreatic cancer	3.43e-05	0.000319	CcSEcCtD
Thiotepa—Diarrhoea—Docetaxel—pancreatic cancer	3.43e-05	0.000319	CcSEcCtD
Thiotepa—Confusional state—Epirubicin—pancreatic cancer	3.41e-05	0.000317	CcSEcCtD
Thiotepa—Infection—Epirubicin—pancreatic cancer	3.36e-05	0.000312	CcSEcCtD
Thiotepa—Cough—Doxorubicin—pancreatic cancer	3.34e-05	0.000311	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—pancreatic cancer	3.32e-05	0.000309	CcSEcCtD
Thiotepa—Nervous system disorder—Epirubicin—pancreatic cancer	3.31e-05	0.000308	CcSEcCtD
Thiotepa—Dizziness—Docetaxel—pancreatic cancer	3.31e-05	0.000308	CcSEcCtD
Thiotepa—Thrombocytopenia—Epirubicin—pancreatic cancer	3.31e-05	0.000308	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—pancreatic cancer	3.31e-05	0.000308	CcSEcCtD
Thiotepa—Tachycardia—Epirubicin—pancreatic cancer	3.3e-05	0.000307	CcSEcCtD
Thiotepa—Skin disorder—Epirubicin—pancreatic cancer	3.28e-05	0.000306	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—pancreatic cancer	3.26e-05	0.000304	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—pancreatic cancer	3.26e-05	0.000304	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—pancreatic cancer	3.25e-05	0.000303	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.24e-05	0.000301	CcSEcCtD
Thiotepa—Anorexia—Epirubicin—pancreatic cancer	3.22e-05	0.0003	CcSEcCtD
Thiotepa—Vomiting—Docetaxel—pancreatic cancer	3.19e-05	0.000296	CcSEcCtD
Thiotepa—Rash—Docetaxel—pancreatic cancer	3.16e-05	0.000294	CcSEcCtD
Thiotepa—Dermatitis—Docetaxel—pancreatic cancer	3.16e-05	0.000294	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—pancreatic cancer	3.15e-05	0.000293	CcSEcCtD
Thiotepa—Headache—Docetaxel—pancreatic cancer	3.14e-05	0.000292	CcSEcCtD
Thiotepa—Infection—Doxorubicin—pancreatic cancer	3.11e-05	0.000289	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.08e-05	0.000287	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—pancreatic cancer	3.07e-05	0.000285	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.06e-05	0.000285	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—pancreatic cancer	3.05e-05	0.000284	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—pancreatic cancer	3.04e-05	0.000283	CcSEcCtD
Thiotepa—Paraesthesia—Epirubicin—pancreatic cancer	3.03e-05	0.000282	CcSEcCtD
Thiotepa—Somnolence—Epirubicin—pancreatic cancer	3e-05	0.00028	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—pancreatic cancer	2.98e-05	0.000277	CcSEcCtD
Thiotepa—Nausea—Docetaxel—pancreatic cancer	2.98e-05	0.000277	CcSEcCtD
Thiotepa—Dyspepsia—Epirubicin—pancreatic cancer	2.97e-05	0.000277	CcSEcCtD
Thiotepa—Decreased appetite—Epirubicin—pancreatic cancer	2.94e-05	0.000273	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.92e-05	0.000272	CcSEcCtD
Thiotepa—Fatigue—Epirubicin—pancreatic cancer	2.91e-05	0.000271	CcSEcCtD
Thiotepa—Pain—Epirubicin—pancreatic cancer	2.89e-05	0.000269	CcSEcCtD
Thiotepa—Constipation—Epirubicin—pancreatic cancer	2.89e-05	0.000269	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.85e-05	0.000265	CcSEcCtD
Thiotepa—Paraesthesia—Doxorubicin—pancreatic cancer	2.81e-05	0.000261	CcSEcCtD
Thiotepa—Feeling abnormal—Epirubicin—pancreatic cancer	2.78e-05	0.000259	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—pancreatic cancer	2.78e-05	0.000259	CcSEcCtD
Thiotepa—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.76e-05	0.000257	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—pancreatic cancer	2.75e-05	0.000256	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—pancreatic cancer	2.72e-05	0.000253	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.7e-05	0.000251	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—pancreatic cancer	2.7e-05	0.000251	CcSEcCtD
Thiotepa—Urticaria—Epirubicin—pancreatic cancer	2.68e-05	0.00025	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—pancreatic cancer	2.67e-05	0.000249	CcSEcCtD
Thiotepa—Pain—Doxorubicin—pancreatic cancer	2.67e-05	0.000249	CcSEcCtD
Thiotepa—Abdominal pain—Epirubicin—pancreatic cancer	2.67e-05	0.000249	CcSEcCtD
Thiotepa—Body temperature increased—Epirubicin—pancreatic cancer	2.67e-05	0.000249	CcSEcCtD
Thiotepa—Feeling abnormal—Doxorubicin—pancreatic cancer	2.58e-05	0.00024	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.56e-05	0.000238	CcSEcCtD
Thiotepa—Hypersensitivity—Epirubicin—pancreatic cancer	2.49e-05	0.000232	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—pancreatic cancer	2.48e-05	0.000231	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—pancreatic cancer	2.47e-05	0.00023	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—pancreatic cancer	2.47e-05	0.00023	CcSEcCtD
Thiotepa—Asthenia—Epirubicin—pancreatic cancer	2.42e-05	0.000226	CcSEcCtD
Thiotepa—Pruritus—Epirubicin—pancreatic cancer	2.39e-05	0.000223	CcSEcCtD
Thiotepa—Diarrhoea—Epirubicin—pancreatic cancer	2.31e-05	0.000215	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—pancreatic cancer	2.3e-05	0.000214	CcSEcCtD
Thiotepa—Asthenia—Doxorubicin—pancreatic cancer	2.24e-05	0.000209	CcSEcCtD
Thiotepa—Dizziness—Epirubicin—pancreatic cancer	2.23e-05	0.000208	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—pancreatic cancer	2.21e-05	0.000206	CcSEcCtD
Thiotepa—Vomiting—Epirubicin—pancreatic cancer	2.15e-05	0.0002	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—pancreatic cancer	2.14e-05	0.000199	CcSEcCtD
Thiotepa—Rash—Epirubicin—pancreatic cancer	2.13e-05	0.000198	CcSEcCtD
Thiotepa—Dermatitis—Epirubicin—pancreatic cancer	2.13e-05	0.000198	CcSEcCtD
Thiotepa—Headache—Epirubicin—pancreatic cancer	2.12e-05	0.000197	CcSEcCtD
Thiotepa—Dizziness—Doxorubicin—pancreatic cancer	2.07e-05	0.000192	CcSEcCtD
Thiotepa—Nausea—Epirubicin—pancreatic cancer	2.01e-05	0.000187	CcSEcCtD
Thiotepa—Vomiting—Doxorubicin—pancreatic cancer	1.99e-05	0.000185	CcSEcCtD
Thiotepa—Rash—Doxorubicin—pancreatic cancer	1.97e-05	0.000183	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—pancreatic cancer	1.97e-05	0.000183	CcSEcCtD
Thiotepa—Headache—Doxorubicin—pancreatic cancer	1.96e-05	0.000182	CcSEcCtD
Thiotepa—Nausea—Doxorubicin—pancreatic cancer	1.86e-05	0.000173	CcSEcCtD
